Indias Food And Drug Administration

Rediff.com » News » Indias Food And Drug Administration

News for Indias Food And Drug Administration

News
Business

USTR Report Intensifies Trade Tensions With India

The US Trade Representative noted that India's average applied tariff rate stood at 17% per cent, the highest of any major world economy. Kindly note the image has been posted only for......

Adulterated Drugs On Decline Amid Crackdown

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs. Photograph: Yves Herman/Reuters The......

The Coming Dementia Epidemic

Around 7.4 per cent of Indians aged 60 and above are affected by dementia.This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase. Kindly......

Indians Dominate TIME 100 AI Titans List

The TIME 100 AI list is an interesting assortment of titans.Indians make up about 20 per cent of the coveted list, which is pretty commendable, notes Sandeep Goyal. Illustration: Dominic......

Tirupati laddu row: Govt to wait for FSSAI report before action

Amid the ongoing controversy over Tirupati laddu, Consumer Affairs Secretary Nidhi Khare on Monday said her department will consider additional measures to monitor ghee quality in the market only......

USTR flags hurdles in medical device exports to India

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as......

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse......

Trump's tariffs: How will these sectors in India be impacted?

Goods from sectors, including agriculture, precious stones, chemicals, pharma, medical devices, electricals, and machinery may get impacted if the US will go ahead with imposing reciprocal tariffs......

Equity market volatility may persist; long-term outlook remains constructive: Experts

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts......

'Real growth and opportunity are going to come from GLP-1'

'It is not just the US and European opportunity, but it is a huge global opportunity.' Photograph: Kind courtesy Biocon The peptides and GLP-1 class of drugs that are offering breakthrough......

Rediff News

Indias Food And Drug Administration

News for Indias Food And Drug Administration

USTR Report Intensifies Trade Tensions With India

Adulterated Drugs On Decline Amid Crackdown

The Coming Dementia Epidemic

Indians Dominate TIME 100 AI Titans List

Tirupati laddu row: Govt to wait for FSSAI report before action

USTR flags hurdles in medical device exports to India

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Trump's tariffs: How will these sectors in India be impacted?

Equity market volatility may persist; long-term outlook remains constructive: Experts

'Real growth and opportunity are going to come from GLP-1'

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS